DUPONT E I DE NEMOURS & CO

Transcription

1 DUPONT E I DE NEMOURS & CO FORM 8-K (Current report filing) Filed 01/27/15 for the Period Ending 01/27/15 Address 1007 MARKET ST WILMINGTON, DE Telephone CIK Symbol DD SIC Code Plastics Materials And Synthetic Resins, Synthetic Industry Chemical Manufacturing Sector Basic Materials Fiscal Year 12/31 Copyright 2015, EDGAR Online, Inc. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, Inc. Terms of Use.

2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): January 27, 2015 E. I. du Pont de Nemours and Company (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction (Commission (I.R.S. Employer Of Incorporation) File Number) Identification No.) 1007 Market Street Wilmington, Delaware (Address of principal executive offices) Registrant s telephone number, including area code: (302) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR ) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR e-4(c))

3 Item 2.02 Results of Operations and Financial Condition On January 27, 2015, the Registrant announced its consolidated financial results for the quarter ended December 31, A copy of the press release and related presentation are filed herewith as Exhibits 99.1 and 99.2, respectively. Item 9.01 (d) Exhibits: Financial Statements and Exhibits 99.1 Press Release dated January 27, DuPont Fourth Quarter and Full Year 2014 Earnings Presentation dated January 27, 2015

4 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. E. I. DU PONT DE NEMOURS AND COMPANY (Registrant) January 27, 2015 /s/ Barry J. Niziolek Barry J. Niziolek Vice President and Controller

5 Exhibit 99.1 January 27, 2015 Media Contact: Dan Turner WILMINGTON, Del Investor Contact: DuPont Reports 4Q and Full-Year 2014 Operating EPS of $0.71 and $4.01; 4Q and Full-Year EPS in Line with Company Expectations Despite Macroeconomic Headwinds Increases Total Expected Cost Savings from Operational Redesign to at Least $1.3 Billion; Accelerates Year End 2015 Annual Run Rate to $1 Billion Expects to Return to Shareholders All or Substantially All of Anticipated Chemours One-Time Dividend Proceeds, Currently Estimated at $4 Billion, via Share Repurchases Within 12 to 18 months of the Mid-Year Separation WILMINGTON, Del., Jan. 27, DuPont today announced fourth quarter 2014 operating earnings of $0.71 per share compared to $0.59 per share in the prior year. GAAP 1 earnings from continuing operations were $668 million or $0.73 per share, versus $183 million or $0.19 per share last year. Fourth quarter results reflect a 20- percent increase in operating earnings per share year-over-year realized from a number of company actions, including strategic portfolio initiatives, continued productivity improvements related to the company s operational redesign, reductions in performance-based compensation, and share repurchases. For the full year 2014, DuPont delivered operating earnings of $4.01 per share compared to $3.88 per share in the prior year. GAAP 1 earnings from continuing operations were $3.90 per share, versus $3.04 per share last year. Volume, margins and earnings grew in the majority of segments, despite significant market and macroeconomic challenges, including a weaker Ag economy, a stronger dollar and a difficult market pricing environment. "Our 2014 results demonstrate continued progress on our strategic plan to deliver higher growth and higher value, including ongoing portfolio refinement through several strategic portfolio actions and steady progress on the planned Chemours separation, substantial cost reductions from our operational redesign and productivity initiatives, and the continued return of capital to our shareholders through $2 billion of share repurchases and an increase in the common stock dividend of 4 percent," Kullman said. "Rapid progress in our redesign initiative has enabled us to achieve a $1 billion run-rate target by year end 2015, well ahead of schedule, and we have identified at least $300 million of additional opportunities to streamline our operations and reduce costs. This initiative remains a priority and we expect to see further results over time," Kullman added. "In 2015, we remain focused on generating superior returns for our shareholders, including through return of capital from the expected Chemours dividend, while positioning DuPont for our next stage of growth." 1 Generally Accepted Accounting Principles (GAAP) E.I. du Pont de Nemours and Company

6 Company Increases Cost Reduction Commitment and Outlines Expectations for Return of Capital From Chemours One-Time Dividend The company has increased its cost reduction commitment from its operational redesign by approximately $300 million to at least $1.3 billion of total expected savings by Additionally, by the end of 2015, the company now expects annual run-rate savings of approximately $1 billion, significantly ahead of its previously announced schedule. In addition the company said it expects to return all or substantially all of the one-time dividend proceeds from Chemours to DuPont shareholders via share repurchases over the 12 to 18 months following the separation of Chemours. Based on the target BB credit rating of Chemours, this amount is anticipated to be approximately $4 billion, pending the final credit ratings and underlying business conditions for Chemours. Fourth Quarter Highlights Sales were $7.4 billion versus $7.7 billion in the same period last year, down 5 percent primarily due to portfolio changes and negative currency impacts. Volume grew in all segments except for Electronics & Communications. Segment operating earnings were $1,014 million, reflecting disciplined execution despite macroeconomic headwinds, including a weaker Ag economy and the impact from a stronger U.S. dollar. Cost reductions from operational redesign contributed $0.05 per share to operating earnings in the quarter. Full Year Highlights Sales were $34.7 billion versus $35.7 billion last year, down 3 percent due to weakness in Ag markets, portfolio changes and negative currency impacts. A 1-percent increase in volume was offset by price. Segment operating earnings of $6.0 billion increased 1 percent versus $5.9 billion last year as the negative impact of portfolio changes and currency were more than offset by continued productivity improvements, lower performance-based compensation and gains from business divestitures. Continued to execute on our plan to deliver higher growth and higher value for our shareholders: Cost reductions from operational redesign contributed $0.07 per share to operating earnings in 2014; Completed 10 strategic portfolio actions during the year; Completed a $2 billion share buyback; and Increased the common stock dividend 4 percent in July The Chemours separation remains on track, as highlighted by the initial Form 10 filing on December 18. 2

7 3 Global Consolidated Net Sales - 4th Quarter Fourth quarter 2014 net sales of $7.4 billion decreased 5 percent versus last year, reflecting a 4-percent impact from portfolio changes, 1-percent lower local selling prices and a 3-percent negative currency impact, partially offset by 3-percent higher volume. The table below shows fourth quarter regional sales and variances versus fourth quarter Three Months Ended December 31, 2014 (Dollars in millions) $ % Change Local Price Percentage Change Due to: Currency Effect Volume Portfolio/ Other U.S. & Canada $ 2,580 (3) (3) 6 (6) EMEA* 1,672 (5) 2 (6) 3 (4) Asia Pacific 1,910 (4) (2) (2) 2 (2) Latin America 1,216 (10) (3) (5) (1) (1) Total Consolidated Sales $ 7,378 (5 ) (1 ) (3 ) 3 (4 ) * Europe, Middle East & Africa

8 4 Segment Sales - 4th Quarter The table below shows fourth quarter 2014 segment sales with related variances versus the fourth quarter Three Months Ended December 31, 2014 Percentage Change Due to: (Dollars in millions) $ % Change USD Price Volume Portfolio/Other Agriculture $ 1,732 (4) (8) 5 (1) Electronics & Communications 573 (11) (6) (5) Industrial Biosciences 322 (1) (3) 2 Nutrition & Health 843 (3) (4) 1 Performance Chemicals 1,564 (6) (4) 3 (5) Performance Materials 1,461 (4) 4 (8) Safety & Protection 943 (3) (1) 3 (5) Other 1 Total segment sales 7,439 Elimination of transfers (61) Consolidated net sales $ 7,378 Operating Earnings - 4th Quarter Change vs (Dollars in millions) 4Q14 4Q13 $ % Agriculture $ 129 $ 88 $ % Electronics & Communications % Industrial Biosciences % Nutrition & Health % Performance Chemicals (1) (2) -1 % Performance Materials (1) % Safety & Protection % Other (112) (96) (16) -17 % Total segment operating earnings (2) 1, % Exchange gains (losses) (3) 122 (73) 195 Corporate expenses (144) (191) 47 Interest expense (87) (108) 21 Operating earnings before income taxes % Provision for income taxes on operating earnings (256) (9) (247) Net income attributable to noncontrolling interests Operating earnings $ 649 $ 558 $ % Operating earnings per share $ 0.71 $ 0.59 $ % (1) Prior period reflects the reclassifications of the Viton fluoroelastomer product line from Performance Materials to Performance Chemicals. (2) See Schedules B and C for listing of significant items and their impact by segment. (3) See Schedule D for additional information on exchange gains and losses.

9 5 Global Consolidated Net Sales - Full Year Full-year 2014 net sales of $34.7 billion decreased 3 percent versus last year, reflecting a 2-percent impact from portfolio changes, 1-percent lower local selling prices and a 1- percent negative currency impact, partially offset by 1-percent higher volume. The table below shows full-year regional sales and variances versus full year Months Ended December 31, 2014 (Dollars in millions) $ % Change Local Price Percentage Change Due to: Currency Effect Volume Portfolio/ Other U.S. & Canada $ 14,054 (5) (1) (1) (3) EMEA* 8, (1) Asia Pacific 7,703 (1) (2) (2) 4 (1) Latin America 4,483 (6) (1) (3) (1) (1) Total Consolidated Sales $ 34,723 (3 ) (1 ) (1 ) 1 (2 ) * Europe, Middle East & Africa Segment Sales - Full Year The table below shows full-year 2014 segment sales with related variances versus the prior year. 12 Months Ended Percentage Change December 31, 2014 Due to: (Dollars in millions) $ % Change USD Price Volume Portfolio/Other Agriculture $ 11,304 (4) (1) (3) Electronics & Communications 2,393 (6) (8) 2 Industrial Biosciences 1, Nutrition & Health 3,529 2 (1) 3 Performance Chemicals 6,497 (6) (4) 2 (4) Performance Materials 6,129 (2) 2 (4) Safety & Protection 3,896 (1) 3 (2) Other 5 Total segment sales 35,011 Elimination of transfers (288) Consolidated net sales $ 34,723

10 6 Operating Earnings - Full Year Change vs (Dollars in millions) FY 2014 FY 2013 $ % Agriculture $ 2,352 $ 2,483 $ (131) -5 % Electronics & Communications % Industrial Biosciences % Nutrition & Health % Performance Chemicals (1) 934 1,015 (81) -8 % Performance Materials (1) 1,298 1, % Safety & Protection % Other (369) (345) (24) -7 % Total segment operating earnings (2) 5,955 5, % Exchange gains (losses) (2), (3) 193 (128) 321 Corporate expenses (702) (762) 60 Interest expense (377) (448) 71 Operating earnings before income taxes 5,069 4, % Provision for income taxes on operating earnings (1,355) (941) (414) Net income attributable to noncontrolling interests (3) Operating earnings $ 3,703 $ 3,632 $ 71 2 % Operating earnings per share $ 4.01 $ 3.88 $ % (1) Prior period reflects the reclassifications of the Viton fluoroelastomer product line from Performance Materials to Performance Chemicals. (2) See Schedules B and C for listing of significant items and their impact by segment. (3) See Schedule D for additional information on exchange gains and losses.

11 The following is a summary of business results for each of the company s reportable segments comparing fourth quarter with the prior year, unless otherwise noted. References to selling price are on a U.S. dollar basis, including the impact of currency. Fourth quarter results included about $175 million of year-over-year lower performance-based compensation. The impact by segment is as follows: Agriculture - $90 million, Electronics & Communications - $10 million, Industrial Biosciences - $5 million, Nutrition & Health - $10 million, Performance Chemicals - $30 million, Performance Materials - $15 million, and Safety & Protection - $15 million. Full year results included a year-over-year benefit of about $200 million due to lower performance-based compensation, of which $110 million impacted Agriculture. Agriculture - Operating earnings of $129 million increased $41 million, or 47 percent. Lower corn seed sales in Brazil and a negative currency impact were more than offset by lower costs, gains from the sale of businesses of $36 million and the timing of seed shipments. Full year 2014 operating earnings of $2.4 billion decreased $0.1 billion, or 5 percent, on lower corn seed volumes and the negative impact of currency, partially offset by higher crop protection volumes, higher local seed prices, and lower costs, including seed inputs. Electronics & Communications - Operating earnings of $97 million increased $4 million, or 4 percent, as lower costs and productivity improvements were offset by lower Solamet paste volumes due to the impact of competitive pressures. Full year 2014 operating earnings of $355 million increased $21 million, or 6 percent, on volume growth and productivity gains, partially offset by the absence of $20 million in OLED licensing income realized during Industrial Biosciences - Operating earnings of $49 million increased $9 million, or 23 percent, primarily from improved product mix, lower costs and productivity improvements. Full year 2014 operating earnings of $211 million increased $42 million, or 25 percent, on increased enzyme demand, principally for ethanol production, and productivity improvements. Nutrition & Health - Operating earnings of $82 million were essentially flat with prior year as the negative impact of currency and product mix were offset by higher volumes, a gain on termination of a distribution agreement of $18 million, and lower costs. Full year 2014 operating earnings of $380 million increased $81 million, or 27 percent, from improved product mix, volume growth, productivity and a gain on termination of a distribution agreement of $18 million, partially offset by the negative impact of currency. Performance Chemicals - Operating earnings of $228 million decreased $2 million as lower prices for titanium dioxide and fluoroproducts were essentially offset by volume increases, lower costs, and a gain from the sale of a business of $23 million. Full year 2014 operating earnings of $934 million decreased $81 million, or 8 percent, as lower prices for refrigerants, titanium dioxide, and fluoroproducts were partially offset by volume increases, lower costs, and a gain from the sale of a business of $23 million. Performance Materials - Operating earnings of $332 million increased $38 million, or 13 percent, due primarily to increased ethylene and performance polymer volumes, productivity improvements, and lower costs. Full year 2014 operating earnings of $1.3 billion were essentially equal to prior year, as increased automotive demand was offset by the impact of the sale of GLS/Vinyls. Safety & Protection - Operating earnings of $209 million were flat with prior year as lower local prices, currency, and portfolio changes associated with the sale of Sontara were offset by increased demand for Nomex thermal resistant products, Kevlar high strength materials and Tyvek protective material, and lower costs. Full year 2014 operating earnings of $794 million increased $104 million, or 15 percent, from higher volumes driven by increased demand for Nomex and Kevlar, productivity improvements, and lower product costs, partially offset by lower sales from clean technologies offerings, a negative currency impact, and portfolio changes. Ad ditional information is available on the DuPont Investor Center website at 7

12 8 Outlook The company expects 2015 operating earnings of $4.00 to $4.20 per share, including the full-year outlook for the Performance Chemicals segment. This estimate includes an approximately $0.60 per share negative currency impact due to the recent strengthening of the dollar based upon an average basket of exchange rates for our business at January 23. The currency impact is expected to be most significant in the first half of the year due to the seasonality of operating earnings from Agriculture in the northern hemisphere. In 2015, the company anticipates that the increase in the base tax rate from prior year will be about a $0.15 per share headwind. The company also expects that the operational redesign will deliver savings of about $0.35 per share in The 2015 outlook does not reflect the planned separation of the Performance Chemicals segment or the impact of the expected return of capital related to the separation. DuPont will hold a conference call and webcast on Tuesday, January 27, 2015, at 9:00 AM EDT to discuss this news release. The webcast and additional presentation materials can be accessed by visiting the company s investor website ( Events & Presentations ) at A replay of the conference call webcast will be available for 90 days by calling , Passcode #. For additional information see the investor center at Use of Non-GAAP Measures Management believes that certain non-gaap measurements are meaningful to investors because they provide insight with respect to ongoing operating results of the company. Such measurements are not recognized in accordance with GAAP and should not be viewed as an alternative to GAAP measures of performance. Reconciliations of non- GAAP measures to GAAP are provided in schedules A, C and D. DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit Forward-Looking Statements : This news release contains forward-looking statements which may be identified by their use of words like plans, expects, will, believes, intends, estimates, anticipates or other words of similar meaning. All statements that address expectations or projections about the future, including statements about the company s growth strategy, product development, regulatory approval, market position, anticipated benefits of acquisitions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward-looking statements. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company s control. Some of the important factors that could cause the company s actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; significant litigation and environmental matters; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, weather events and natural disasters; ability to protect and enforce the company's intellectual property rights; successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses and successful completion of the proposed spinoff of the Performance Chemicals segment including ability to fully realize the expected benefits of the proposed spinoff. The company undertakes no duty to update any forward-looking statements as a result of future developments or new information. ADDITIONAL INFORMATION AND WHERE TO FIND IT DuPont intends to file a proxy statement with the U.S. Securities and Exchange Commission (the "SEC") with respect to the 2015 Annual Meeting. DUPONT STOCKHOLDERS ARE STRONGLY ENCOURAGED TO READ ANY SUCH PROXY STATEMENT, THE ACCOMPANYING WHITE PROXY CARD AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. DuPont, its directors, executive officers and other employees may be deemed to be participants in the solicitation of proxies from DuPont stockholders in connection with the matters to be considered at DuPont s 2015 Annual Meeting. Information about DuPont s directors and executive officers is available in DuPont s proxy statement, dated March 14, 2014, for its 2014 Annual Meeting. To the extent holdings of DuPont s securities by such directors or executive officers have changed since the amounts printed in the 2014 proxy statement, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC. More detailed information regarding the identity of potential participants, and their direct or indirect interests, by security holdings or otherwise, will be set forth in the proxy statement and other materials to be filed with the SEC in connection with DuPont s 2015 Annual Meeting. Stockholders will be able to obtain any proxy statement, any amendments or supplements to the proxy statement and other documents filed by DuPont with the SEC free of charge at the SEC's website at Copies will also be available free of charge at DuPont s website at or by contacting DuPont Investor Relations at (302) # # # 01/27/15

13 9 E.I. du Pont de Nemours and Company Consolidated Income Statements (Dollars in millions, except per share amounts) SCHEDULE A Three Months Ended December 31, Twelve Months Ended December 31, Net sales $ 7,378 $ 7,747 $ 34,723 $ 35,734 Other income, net (a) , Total 7,919 7,836 36,046 36,144 Cost of goods sold 4,823 5,132 21,703 22,547 Other operating charges (a) ,067 1,560 Selling, general and administrative expenses 1,164 1,350 5,344 5,833 Research and development expense ,067 2,153 Interest expense Employee separation / asset related charges, net (a) Total 6,956 7,714 31,055 32,655 Income from continuing operations before income taxes ,991 3,489 Provision for (benefit from) income taxes on continuing operations (a) 295 (61) 1, Income from continuing operations after income taxes ,621 2,863 Income from discontinued operations after taxes ,999 Net income ,636 4,862 Less: Net income attributable to noncontrolling interests Net income attributable to DuPont $ 683 $ 185 $ 3,625 $ 4,848 Basic earnings per share of common stock (b) : Basic earnings per share of common stock from continuing operations $ 0.73 $ 0.19 $ 3.94 $ 3.07 Basic earnings per share of common stock from discontinued operations Basic earnings per share of common stock $ 0.75 $ 0.20 $ 3.95 $ 5.22 Diluted earnings per share of common stock (b) : Diluted earnings per share of common stock from continuing operations $ 0.73 $ 0.19 $ 3.90 $ 3.04 Diluted earnings per share of common stock from discontinued operations Diluted earnings per share of common stock $ 0.74 $ 0.20 $ 3.92 $ 5.18 Dividends per share of common stock $ 0.47 $ 0.45 $ 1.84 $ 1.78 Average number of shares outstanding used in earnings per share (EPS) calculation: Basic 906,339, ,279, ,752, ,984,000 Diluted 913,650, ,949, ,873, ,147,000 (a) See Schedule B for detail of significant items. (b) The sum of the individual earnings per share amounts may not equal the total due to rounding. Reconciliation of Non-GAAP Measures Summary of Earnings Comparison Three Months Ended December 31, Twelve Months Ended December 31, % Change % Change Income from continuing operations after income taxes (GAAP) $ 668 $ % $ 3,621 $ 2, % Less: Significant items charge (benefit) included in income from continuing operations after income taxes (per Schedule B) 39 (294) (9) (423) Non-operating pension/opeb costs included in income from continuing operations after income taxes (20) (81) (84) (360) Net income attributable to noncontrolling interest Operating earnings (Non-GAAP) $ 649 $ % $ 3,703 $ 3,632 2 % EPS from continuing operations attributable to DuPont (GAAP) $ 0.73 $ % $ 3.90 $ % Significant items charge (benefit) included in EPS (per Schedule B) 0.04 (0.31) (0.01) (0.45) Non-operating pension/opeb costs included in EPS (0.02) (0.09) (0.10) (0.39) Operating EPS (Non-GAAP) $ 0.71 $ % $ 4.01 $ %

14 10 E.I. du Pont de Nemours and Company Condensed Consolidated Balance Sheets (Dollars in millions, except per share amounts) SCHEDULE A (continued) Assets Current assets December 31, 2014 December 31, 2013 Cash and cash equivalents $ 6,910 $ 8,941 Marketable securities Accounts and notes receivable, net 6,005 6,047 Inventories 7,841 8,042 Prepaid expenses Deferred income taxes Assets held for sale 228 Total current assets 21,748 24,384 Property, plant and equipment, net of accumulated depreciation (December 31, $19,942; December 31, $19,438) 13,386 12,993 Goodwill 4,529 4,713 Other intangible assets 4,580 5,096 Investment in affiliates 886 1,011 Deferred income taxes 3,651 2,353 Other assets 1, Total $ 49,876 $ 51,499 Liabilities and Equity Current liabilities Accounts payable $ 4,822 $ 5,180 Short-term borrowings and capital lease obligations 1,423 1,721 Income taxes Other accrued liabilities 5,848 6,219 Total current liabilities 12,640 13,367 Long-term borrowings and capital lease obligations 9,271 10,741 Other liabilities 13,819 10,179 Deferred income taxes Total liabilities 36,498 35,213 Commitments and contingent liabilities Stockholders' equity Preferred stock Common stock, $0.30 par value; 1,800,000,000 shares authorized; Issued at December 31, ,020,000; December 31, ,014,027, Additional paid-in capital 11,174 11,072 Reinvested earnings 17,045 16,784 Accumulated other comprehensive loss (8,707 ) (5,441 ) Common stock held in treasury, at cost (87,041,000 shares at December 31, 2014 and December 31, 2013) (6,727 ) (6,727 ) Total DuPont stockholders' equity 13,320 16,229 Noncontrolling interests Total equity 13,378 16,286 Total $ 49,876 $ 51,499

15 11 E.I. du Pont de Nemours and Company Condensed Consolidated Statement of Cash Flows (Dollars in millions) SCHEDULE A (continued) Total Company Twelve Months Ended December 31, Net income $ 3,636 $ 4,862 Adjustments to reconcile net income to cash used for operating activities: Depreciation 1,254 1,280 Amortization of intangible assets Net periodic pension benefit cost Contributions to pension plans (311 ) (313 ) Gain on sales of businesses (726 ) (2,687 ) Other operating activities - net Change in operating assets and liabilities - net (1,272 ) (1,416 ) Cash provided by operating activities 3,712 3,179 Investing activities Purchases of property, plant and equipment (2,020) (1,882) Investments in affiliates (42) (58) Payments for businesses - net of cash acquired (133) Proceeds from sales of businesses - net 1,058 4,841 Proceeds from sales of assets - net Net decrease (increase) in short-term financial instruments 14 (45) Foreign currency exchange contract settlements Other investing activities - net Cash (used for) provided by investing activities (337) 2,945 Financing activities Dividends paid to stockholders (1,696) (1,661) Net (decrease) increase in borrowings (1,701) 717 Repurchase of common stock (2,000) (1,000) Proceeds from exercise of stock options Payments for noncontrolling interest (65) Other financing activities - net (4) (1) Cash used for financing activities (5,074) (1,474) Effect of exchange rate changes on cash (332 ) (88 ) (Decrease) increase in cash and cash equivalents (2,031 ) 4,562 Cash and cash equivalents at beginning of period 8,941 4,379 Cash and cash equivalents at end of period $ 6,910 $ 8,941 Reconciliation of Non-GAAP Measure Calculation of Free Cash Flow - Total Company Twelve Months Ended December 31, Cash provided by operating activities $ 3,712 $ 3,179 Purchases of property, plant and equipment (2,020 ) (1,882 ) Free cash flow $ 1,692 $ 1,297

16 12 E.I. du Pont de Nemours and Company Schedule of Significant Items from Continuing Operations (Dollars in millions, except per share amounts) SCHEDULE B SIGNIFICANT ITEMS FROM CONTINUING OPERATIONS Pre-tax After-tax ($ Per Share) st Quarter Separation transaction costs (a) $ (16) $ $ (12) $ $ (0.01) $ Customer claims charge (e) (35) (22) (0.02) Income tax items (f) st Quarter - Total $ (16) $ (35) $ (12) $ 20 $ (0.01) $ nd Quarter Separation transaction costs (a) $ (35) $ $ (26) $ $ (0.03) $ Gain on sale of business (b) Restructuring charge (c) (263) (182) (0.20) Venezuela devaluation (d) (58) (57) (0.06) Customer claims charge (e) (80) (51) (0.05) Income tax items (g) (11) (27) (0.03) 2nd Quarter - Total $ 35 $ (91) $ 8 $ (78) $ 0.01 $ (0.08) 3rd Quarter Separation transaction costs (a) $ (61) $ $ (44) $ $ (0.05) $ Customer claims charge (e) (40) (24) (0.03) Litigation settlement (h) (72) (47) (0.05) 3rd Quarter - Total $ (61) $ (112) $ (44) $ (71) $ (0.05) $ (0.08) 4th Quarter Separation transaction costs (a) $ (63) $ $ (49) $ $ (0.05) $ Customer claims recovery (charge) (e) 210 (197) 134 (129) 0.14 (0.13) Gain on sale of business (b) Restructuring charge/adjustments (c) (299) (124) (200) (165) (0.22) (0.18) 4th Quarter - Total $ 88 $ (321) $ 39 $ (294) $ 0.04 $ (0.31) (i) Full Year - Total $ 46 $ (559) $ (9) $ (423) $ (0.01) $ (0.45)

17 13 E.I. du Pont de Nemours and Company Schedule of Significant Items from Continuing Operations (Dollars in millions, except per share amounts) SCHEDULE B (continued) (a) Fourth, third, second and first quarter 2014 included a charge of $(63), $(61), $(35) and $(16), respectively, recorded in other operating charges associated with transaction costs related to the separation of the Performance Chemicals segment. (b) Fourth quarter 2014 included a gain of $240 recorded in other income, net associated with the sale of copper fungicides and land management businesses, both within the Agriculture segment. Second quarter 2014 included a gain of $391 recorded in other income, net associated with the sale of Glass Laminating Solutions/Vinyls in the Performance Materials segment. (c) As a result of the company's plan to reduce residual costs associated with the separation of the Performance Chemicals segment and to improve productivity across all businesses and functions, fourth quarter 2014 included a $(299) restructuring charge consisting of $(234) recorded in employee separation/asset related charges, net, and $(65) recorded in other income, net. The charges include $(153) of severance and related benefit costs, $(14) of other nonpersonnel charges, and $(132) of asset related charges, including $(65) of charges associated with the restructuring actions of a joint venture. Pre-tax charges by segment are: Agriculture - $(87), Electronics & Communications - $(16), Industrial Biosciences - $(11), Nutrition & Health - $(7), Performance Chemicals - $(2), Performance Materials - $(70), Safety & Protection - $(21), Other - $(20), and Corporate expenses - $(65). Similarly, second quarter 2014 included a $(263) restructuring charge recorded in employee separation/asset related charges, net, consisting of $(166) of severance and related benefit costs, $(94) of asset related charges, and $(3) of other non-personnel charges. Pre-tax charges by segment are: Agriculture - $(47), Electronics & Communications - $(68), Industrial Biosciences - $(2), Nutrition & Health - $(8), Performance Chemicals - $(19), Performance Materials - $(29), Safety & Protection - $(31), Other - $(2), and Corporate expenses - $(57). Fourth quarter 2013 included an impairment charge of $(129) recorded in employee separation/asset related charges, net related to an asset grouping within the Electronics & Communications segment. The fourth quarter 2013 charge was the result of strategic decisions related to the thin film photovoltaic market. Fourth quarter 2013 also included a net $5 restructuring adjustment consisting of a $24 benefit associated with prior year restructuring programs and a $(19) charge associated with restructuring actions related to a joint venture. The majority of the $24 net reduction recorded in employee separation/asset related charges, net was due to the achievement of work force reductions through non-severance programs associated with the 2012 restructuring program. The charge of $(19) included $(9) recorded in employee separation/asset related charges, net and $(10) recorded in other income, net and was the result of restructuring actions related to a joint venture within the Performance Materials segment. Pre-tax amounts by segment were: Agriculture-$1, Electronics & Communication-$(2), Industrial Biosciences-$1, Nutrition & Health-$6, Performance Chemicals-$(2), Performance Materials-$(16), Safety & Protection-$4, Other-$5 and Corporate-$8. (d) Second quarter 2014 included a charge of $(58) recorded in other income, net associated with remeasuring the company's Venezuelan net monetary assets from the official exchange rate to the SICAD II exchange system. (e) The company recorded insurance recoveries of $210 in other operating charges, in fourth quarter of 2014 in the Agriculture segment, for recovery of costs for customer claims related to the use of the Imprelis herbicide. The company had accruals of $261 related to these customer claims and insurance receivables of $35 at December 31, The company has submitted and will continue to submit requests for payment to its insurance carriers for costs associated with this matter. To date, the company has recognized and received $283 of insurance recoveries from its insurance carriers and continues to seek recovery although the timing and outcome remain uncertain. Fourth, third, second and first quarter 2013 included charges of $(197), $(40), $(80) and $(35), respectively, recorded in other operating charges in the Agriculture segment associated with resolving claims related to the use of the Imprelis herbicide. (f) First quarter 2013 included a net tax benefit of $42 consisting of a $68 benefit for the 2013 extension of certain U.S business tax provisions offset by a $(26) charge related to the global distribution of Performance Coatings cash proceeds. (g) Second quarter 2013 includes a charge of $(11) in other income, net related to interest on a prior year tax position. Second quarter 2013 also includes a charge of $(49) associated with a change in accrual for a prior year tax position offset by a $33 benefit for an enacted tax law change. (h) Third quarter 2013 included a charge of $(72) recorded in other operating charges related to the company's settlement of titanium dioxide antitrust litigation. This matter relates to the Performance Chemicals segment. (i) Earnings per share for the year may not equal the sum of quarterly earnings per share due to the changes in average share calculations.

18 14 E.I. du Pont de Nemours and Company Consolidated Segment Information (Dollars in millions) SCHEDULE C Three Months Ended December 31, Twelve Months Ended December 31, SEGMENT SALES (1) Agriculture $ 1,732 $ 1,806 $ 11,304 $ 11,739 Electronics & Communications ,393 2,549 Industrial Biosciences ,258 1,224 Nutrition & Health ,529 3,473 Performance Chemicals (2) 1,564 1,671 6,497 6,932 Performance Materials (2) 1,461 1,521 6,129 6,239 Safety & Protection ,896 3,884 Other Total Segment sales 7,439 7,814 35,011 36,046 Elimination of transfers (61 ) (67 ) (288 ) (312 ) Consolidated net sales $ 7,378 $ 7,747 $ 34,723 $ 35,734 (1) Segment sales include transfers. (2) Prior periods reflect the reclassifications of the Viton product line from Performance Materials to Performance Chemicals.

19 15 E.I. du Pont de Nemours and Company Consolidated Segment Information (Dollars in millions) SCHEDULE C (continued) Three Months Ended December 31, Twelve Months Ended December 31, INCOME FROM CONTINUING OPERATIONS (GAAP) Agriculture $ 492 $ (108 ) $ 2,668 $ 2,132 Electronics & Communications 81 (38 ) Industrial Biosciences Nutrition & Health Performance Chemicals (1) Performance Materials (1) ,590 1,264 Safety & Protection Other (132 ) (91 ) (391 ) (340 ) Total Segment PTOI 1, ,356 5,369 Corporate expenses (272) (183) (999) (765) Interest expense (87) (108) (377) (448) Non-operating pension/opeb costs (30) (124) (124) (539) Net exchange gains (losses) (2) 122 (73) 135 (128) Income before income taxes from continuing operations $ 963 $ 122 $ 4,991 $ 3,489 Three Months Ended December 31, Twelve Months Ended December 31, SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX) (3) Agriculture $ 363 $ (196 ) $ 316 $ (351 ) Electronics & Communications (16 ) (131 ) (84 ) (131 ) Industrial Biosciences (11 ) 1 (13 ) 1 Nutrition & Health (7 ) 6 (15 ) 6 Performance Chemicals (1) (2 ) (2 ) (21 ) (74 ) Performance Materials (1) (70 ) (16 ) 292 (16 ) Safety & Protection (21 ) 4 (52 ) 4 Other (20 ) 5 (22 ) 5 Total significant items by segment 216 (329 ) 401 (556 ) Corporate expenses (128 ) 8 (297 ) (3 ) Net exchange gains (losses) (2) (58 ) Total significant items before income taxes $ 88 $ (321 ) $ 46 $ (559 ) Three Months Ended December 31, Twelve Months Ended December 31, OPERATING EARNINGS (NON-GAAP) Agriculture $ 129 $ 88 $ 2,352 $ 2,483 Electronics & Communications Industrial Biosciences Nutrition & Health Performance Chemicals (1) ,015 Performance Materials (1) ,298 1,280 Safety & Protection Other (112 ) (96 ) (369 ) (345 ) Total segment operating earnings 1, ,955 5,925 Corporate expenses (144 ) (191 ) (702 ) (762 ) Interest expense (87 ) (108 ) (377 ) (448 ) Operating earnings before income taxes and exchange gains (losses) ,876 4,715 Net exchange gains (losses) (2) 122 (73 ) 193 (128 ) Operating earnings before income taxes $ 905 $ 567 $ 5,069 $ 4,587 (1) Prior periods reflect the reclassifications of the Viton product line from Performance Materials to Performance Chemicals. (2) See Schedule D for additional information on exchange gains and losses. (3) See Schedule B for detail of significant items.

20 16 E.I. du Pont de Nemours and Company Reconciliation of Non-GAAP Measures (Dollars in millions, except per share amounts) SCHEDULE D Reconciliations of Adjusted EBIT / EBITDA to Consolidated Income Statements Three Months Ended December 31, Twelve Months Ended December 31, Income from continuing operations before income taxes $ 963 $ 122 $ 4,991 $ 3,489 Add: Significant items before income taxes (88 ) 321 (46 ) 559 Add: Non-operating pension/opeb costs Operating earnings before income taxes $ 905 $ 567 $ 5,069 $ 4,587 Less: Net income attributable to noncontrolling interests Add: Interest expense Adjusted EBIT from operating earnings ,435 5,021 Add: Depreciation and amortization ,617 1,603 Adjusted EBITDA from operating earnings $ 1,371 $ 1,062 $ 7,052 $ 6,624 Reconciliation of Operating Earnings Per Share (EPS) Outlook The reconciliation below represents the company's outlook on an operating earnings basis, defined as earnings from continuing operations excluding significant items and non-operating pension/opeb costs. Year Ended December 31, 2015 Outlook 2014 Actual Operating EPS (Non-GAAP) $4.00-$4.20 $ 4.01 Significant items Separation transaction costs (0.30) (0.14) Gain on sale of business 0.47 Restructuring charge (0.42) Venezuela devaluation (0.06) Tax items Customer claims recovery 0.14 Restructuring charge/adjustments Litigation settlement Asset impairment charge Non-operating pension/opeb costs - estimate (0.21 ) (0.10 ) EPS from continuing operations (GAAP) $3.49-$3.69 $ 3.90

21 17 E.I. du Pont de Nemours and Company Reconciliation of Non-GAAP Measures (Dollars in millions, except per share amounts) SCHEDULE D (continued) Exchange Gains/Losses on Operating Earnings (1) The company routinely uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes. The net pre-tax exchange gains and losses are recorded in other income, net and the related tax impact is recorded in provision for (benefit from) income taxes on the Consolidated Income Statements. Subsidiary/Affiliate Monetary Position Gain (Loss) Three Months Ended December 31, Twelve Months Ended December 31, Pre-tax exchange losses (includes equity affiliates) $ (198 ) $ (42 ) $ (414 ) $ (163 ) Local tax (expenses) benefits (73 ) 22 (205 ) 54 Net after-tax impact from subsidiary exchange losses $ (271 ) $ (20 ) $ (619 ) $ (109 ) Hedging Program Gain (Loss) Pre-tax exchange gains (losses) $ 320 $ (31) $ 607 $ 35 Tax (expenses) benefits (112) 12 (212) (12) Net after-tax impact from hedging program exchange gains (losses) $ 208 $ (19) $ 395 $ 23 Total Exchange Gain (Loss) Pre-tax exchange gains (losses) $ 122 $ (73) $ 193 $ (128) Tax (expenses) benefits (185) 34 (417) 42 Net after-tax exchange losses (2) $ (63) $ (39) $ (224) $ (86) As shown above, the "Total Exchange Gain (Loss)" is the sum of the "Subsidiary/Affiliate Monetary Position Gain (Loss)" and the "Hedging Program Gain (Loss)." (1) See Schedule B for detail of significant items. (2) The above net after-tax exchange losses excludes losses attributable to discontinued operations of $(5) for the twelve months ended December 31, Reconciliation of Base Income Tax Rate to Effective Income Tax Rate Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), as defined above, significant items and non-operating pension/opeb costs. Three Months Ended December 31, Twelve Months Ended December 31, Income from continuing operations before income taxes $ 963 $ 122 $ 4,991 $ 3,489 Add: Significant items - (benefit) charge (1) (88 ) 321 (46 ) 559 Non-operating pension/opeb costs Less: Net exchange gains (losses) 122 (73 ) 193 (128 ) Income from continuing operations before income taxes, significant items, exchange gains (losses), and non-operating pension/opeb costs $ 783 $ 640 $ 4,876 $ 4,715 Provision for (benefit from) income taxes on continuing operations $ 295 $ (61) $ 1,370 $ 626 Add: Tax (expenses) benefits on significant items (49) 27 (55) 136 Tax benefits (expenses) on non-operating pension/opeb costs Tax (expenses) benefits on exchange gains/losses (185) 34 (417) 42 Provision for income taxes on operating earnings, excluding exchange gains (losses) $ 71 $ 43 $ 938 $ 983 Effective income tax rate 30.6 % (50.0)% 27.4 % 17.9 % Significant items effect and non-operating pension/opeb costs effect (2.3)% 51.6 % (0.7)% 2.6 % Tax rate, from continuing operations, before significant items and non-operating pension/opeb costs 28.3 % 1.6 % 26.7 % 20.5 % Exchange gains (losses) effect (19.2)% 5.1 % (7.5)% 0.3 % Base income tax rate from continuing operations 9.1 % 6.7 % 19.2 % 20.8 % (1) See Schedule B for detail of significant items.

22 Co nference Call January 27, 2015 DuPont Fourth Quarter and Full Year 2014 Earnings

23 1 Regulation G Th e attached charts include company info rmation that does not conform to generally accepted accounting principles (GAAP). Management believes th at an analysis of this data is meaningful to investors because it prov ides insight with respect to ongoing operating results of the company. These measures should not be viewed as an alternative to GAAP measures of performance. Furthermore, these measures may not be consistent with similar measures provided by other companies. This data should be read in conjunction with prev iously published comp any reports on Forms 10-K, 10 -Q, and 8 -K. These reports, along with reconciliations o f non-gaap measures to GAAP are available on the Investo r Center of und er Filings and Reports Reconciliations and Other Data. Reco nciliations of non-gaap measures to GAAP are also included with this presentatio n. Forward -Looking Statements This document contains forward-looking statements which may be identified by their use of words like plan s, expects, will, believes, intends, estimates, anticipates or oth er words of similar meaning. All statements that address expectations or projections ab out the futu re, includ ing statements about the company's strategy for g rowth, product development, regulatory approval, market position, anticipated benefits of recent acqu isitions, timing of anticip ated benefits from restructuring actions, outco me of contingencies, such as litigation and environmental matters, expend itures and financial results, are fo rward looking statements. Forwar d-looking statements are not guarantees of future performance and are based on certain assumptions and expectation s of future events which may not be realized. Forward-looking statements also involve risks and u ncertainties, many of wh ich are beyond the company s contr ol. Some of the impo rtant factors that could cause the company s actual resu lts to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new p roducts and optimally manage pro duct life cycles; significant litigatio n and environmental matters; failure to appro priately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic an d cap ital markets conditions, such as inflation, interest and currency exchan ge rates; b usiness or supply disruptions; security threats, such as acts of sabotag e, terrorism or war, weather events and natural disasters; abili ty to protect and enforce th e company's intellectu al pr operty rights; successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses and successful completion of the proposed spinoff of the Performance Chemicals segment including ability to fully realize the expected benefits of th e proposed spinoff. The co mpany undertakes no duty to update any forward-lookin g statements as a result of future developments or new information. Developing Markets Total developing markets is comprised of Developing Asia, Developing Europe, Middle East & Africa, and Latin Amer ica. A detailed list of all developing countries is available on the Earnings News Release link on the Investor Center website at Additional Information And Where To Find It DuPont intends to file a proxy statement with the U.S. Securities and Exchange Commission (the "SEC") with respect to the 2015 Annual Meeting. DUPONT STOCKHOLDERS ARE STRONGLY ENCOURAGED TO READ ANY SUCH PROXY STATEMENT, THE ACCOMPANYI NG WHITE PROXY CARD AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY B ECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. DuPont, its directors, executive officers and other employ ees may be deemed to be participants in the solicitation o f proxies fro m DuPont stockholders in connection with the matters to be con sidered at DuPont s 2015 Annual Meeting. In formation about DuPont s d irectors and executive officers is availab le in DuPont s proxy statement, dated March 14, 20 14, for its 2014 Annual Meeting. To the extent holdings of DuPon t s securities by such directors or executive officers have changed since the amounts printed in the 2014 proxy statement, such changes have b een o r will be reflected on Statements of Change in Own ership on Form 4 filed with the SEC. More d etailed information regarding the identity of potential participants, and their direct or indir ect interests, by security holdings or otherwise, will be set forth in the proxy statement and other materials to be filed with the SEC in connection with DuPont s 2015 Annual Meeting. Stockholders will be able to obtain any pr oxy statement, any amendments or supplements to the proxy statement and other documents filed by DuPont with the SEC free of charge at the SEC's website at Copies will also be available free of charge at DuPont s website at pont.com or by contacting DuPont Investor Relations at (302)

24 In troductory Remarks 2 Strong pr ogress in 2014 leaves DuPont poised to deliver higher growth and higher value in 2015 and beyo nd Continued portfolio transformation as a dy namic science company driven by inno vation, ex ecution, and global reach Continued focu s on innovation and development of new products and solutions Initiated oper ational redesign and related cost cutting program Hired world -class management consultant to undertake thorough assessment Increased target cost reductions to $1.3 billion by end of 2017 Progress on Chemour s Reached strategic milestones with initial Form 10 filing in December Separation on track to be completed mid-year Demonstrated commitment to capital retur n $2 billion of common shares repu rchased in 2014 Common stock dividend increased 4 p ercent in July Proceeds from Chemours separation expected to be returned to sharehold ers via share repurchases

25 4Q Financial High lights* $ in millions, except EPS 3 4Q14 vs. 4Q13 FY14 vs. FY13 EPS* Operating earnings* * $ % $4.01 3% GAAP earnings $ % $ % Segment Operating Earnings** $1,014 8% $5,955 1% 4Q14 vs. 4Q1 3 FY14 v s. FY13 Consolidated Net Sales* $7,378 (5%) $34,723 (3%) Volume 3% 1% Local Prices (1%) (1%) Currency Impact (3 %) (1%) Portfolio (4%) (2%) * Amounts reflect continuing operations ** See append ix for reconciliations of Non-GAAP Measures

26 4Q 2014 Segment Operating Earnings* Variance ($ in millions) 4 * See appendix for details of significant items and reconciliation of Non-GAAP Measur es Growth in Agriculture driven by the timing of seed sh ipments, hig her crop protection volumes, lower costs and gains from the sale of businesses, partially offset by lower corn seed sales in Brazil and negative currency impact Performance Materials results driven by demand for ethylene and performance polymers, co ntinued produ ctivity and lower costs Safety & Protection results were flat as increased demand in industrial markets and lo wer costs were offset by lower local price, curren cy and the impact of portfolio changes Other reflects higher expenses asso ciated with pre-commercial programs Segment results include a benefit of approx. $175 million due to lower performance-based compensation year over year. Impact by segment is as follows: Ag riculture - $90 million, Electronics & Communicatio ns - $10 million, Industrial Biosciences - $5 million, Nutritio n & Health - $10 million, Performance Chemicals - $30 million, Performance Materials - $15 million, and Safety & Protection - $15 million Key Factors $41 $9 $1 ($16) $38 $4 ($2) 4Q13 Ag Perf Mtls IB E&C N&H Perf Chem S&P Other 4Q14 $939 Seg ment Operating Earnings* $1,014 Segment Operating Earn ings* ($0)

27 Collaboration Speeds Innovation 2013 High lights Global Sales Regional Highlights 5 U.S. & Canada 35% Developing EMEA 8% Developed EMEA 15% Developing Asia 16% Developed Asia 10% Latin America 1 6% Region % Worldwide -5% U.S. & Canada -3% Developed EMEA -8% Developed Asia -13% Developing Markets -3% Developing Asia +3% Developing EMEA +4% Latin America -10% 4Q 2014 Sales by Region 4Q 2014 Sales YOY% Change

28 4Q 2014 Operating EPS* Variance 6 * See appendix for details of significant items and reconciliation of Non-GAAP Measures Seg ment earnings, excluding portfolio changes, were up $0.09, as lower costs and additional gains from portfolio actions of $90 million were partially offset by a weaker Ag economy and a stronger U.S. dollar Lower corp orate and interest expen se and lower shares o utstanding together contributed $0.09 to the quarter Portfolio actions in clude the impact of previous divestitures as well as the sales of copp er fungicides (Kocid e and ManKocide ), Lan d Management business, Asana insecticid es, Dymel pharmaceutical grade propellants, and the alfalfa seed b usiness in the quarter Key Factors $0.59 Operating* EPS $0.09 $0.07 $0.02 ($ 0.03) ($0.03) $0.71 Operating* EPS 4Q13 Segment results Portfolio changes Corp & I nterest Exp EGL Lower shares 4Q14

29 Balance Sheet and Cash December 31, Free Cash Flow ~$ 0.4B improvement YOY Absence of prior -year tax p ayments related to the sale o f Performance C oatings Balance Sheet $3.7B net debt** $2.0B in share repurchases about 30 million shares retired ~ $3.7B increase in unfunded pension & OPEB liability due to ch ange in discount rates and mortality tables Uses of Cash in ~$ 1.4B debt maturity in 1Q 2015 ~$ 1.7B for normal div idends Continued gr owth investments in line with strategy YTD 13 YTD 14 $ B il li o n s Jun-13 Sep-13 Dec -13 Mar-14 Jun-14 Sep-14 Dec-14 $ B ill io n s Gross Debt Cash Net Debt** Free Cash Flow* Cash and Debt * Free Cash Flow is cash provided by operating activities of $3,7 12MM and $3,179MM less purchases o f plant, property and equipment of $2,020MM and $1,88 2MM for the year ended December 31, 2014 an d 2013, respectively. ** See appendix fo r reconciliation of Non- GAAP measures.

30 2013 Highlights Other Financial Highlig hts 8 Increased total expected cost savings from operational redesign to at least $1.3 billion Redesign initiative on track and contributed $0.05 per share to operating earnings in the quarter; $0.07 per share fo r full year 2014 On track to complete Performance C hemicals separatio n mid 2015: Initial For m 10 filed in December 2014 Targeting a high yield credit rating of BB Expect to return all or substantially all of anticipated Chemours one-time dividend proceeds to shareholders via share repurchases within months of separation

31 20 15 Assumptions 9 Key Market Summary Macro economic Outloo k Ag sector remains challenged Farmer net income has declined Expect lower corn plan ted area Global light vehicle builds expected to rise nearly 3% Strong gr owth in p hotovoltaics driven by h igher global module installations U.S. housing starts up ~15% Dollar stronger against most currencies Global GDP 3% Industrial Production 3% Acceleration in US manufacturing Continued uncertainty in Europe and Japan China growth slowing

32 2015 Expectations and Outlook 10 Net sales even with prior year, ~ 5 percen t growth fr om volume and local price offset by portfo lio changes and impact of currency Operating EPS* earnings range of $ $4.20 per share Includes Performan ce Ch emicals Includes currency headwind of ~$0.60 per share Base tax rate ~22% Increase due to expected geog raphical mix of earnings and absence of US R&D credit ~$ 0.15 per share head wind in Capital Expenditures ~$1.8B Items excluded from Oper ating Earnings*: Non -operating pen sion expense ~ $0.21per share; increase from 2014 due to discou nt rates Transaction costs for Performance Chemical separation ~$0.30 per share * See appendix fo r reconciliation of Non-GAAP measures

33 * Segment sales include transfers. **See appendix for reconciliation of non -GAAP measures. Agriculture Pioneer, Crop Protection Q12 4Q13 4Q14 $ in Billio n s 4Q12 4Q13 4Q14-8.0% -4.0 % 0.0% 4.0% 8.0% M a rg in $ in M ill io n s 1Q and FY Outlook 1Q: Sales - About 10 percent lower primarily driven by cur rency, lower corn planted area, timing of seed shipments, and lower herbicide volumes; Operating Earnings - About 25 percent lower Economic environment in th e agr iculture sector challenged and corn volumes will be under pressure from lower planted area Currency impact will be greatest in the first quarter wh en th e majority of sales in Europe occu r Exp ect local p rice gains fr om new pro duct mix Full-Year: Sales - Low-single digits percent lower; Operating Earnings - High -single digits percent lo wer; primarily due to currency; ex-cu rrency, up mid - to high-single digit percent Confident in long -term su stainable demand growth and Ag pipeline 4Q C omments Sales - 4 percent lower as a 5 percent increase in volumes was offset by 8 percent lower USD pricing from both currency and local price and a 1 percent decline from portfolio Volume growth from crop protection and the timing of seed ship ments in North America and Europe for the 2015 planting season Lower cor n seed vo lume and pr ice in Brazil reflecting lower planted area and the impact of in sect r esistance Operating Earnings - $129 million increased $41 million as lower costs, productiv ity improvements and gains from portfolio actions of $36 million more than offset the sales decline 4Q Operating Earnings** 4Q Sales*

34 Performance Materials*** Performance Polymers (DPP), Packaging & Industrial Polymers (P&IP) Q12 4Q13 4Q14 $ in Billio n s 4Q12 3Q13 4Q14 0% 5% 10% 15% 20% 25% M a rg in $ in M ill io n s 4Q C omments Sales - Positive volume and lo cal pricing were more than offset b y currency and portfolio impact, resulting in a decline of 4 percent Segment volume increased 4 percent on solid demand in auto, p ackaging, industrial and consu mer markets China and North American demand strong in the auto sector Operating Earnings - Up 13 percent as hig her volume, prices, and lower costs more than offset negative impacts from currency an d portfolio changes Operating margins increased 340 bps on favorable ethylene dynamics and higher volumes 1Q and FY Outlook 1Q: Sales - Down mid-single digits due to currency and portfolio changes, ex portfolio and currency up mid single digits Operating Earnings - Increase in the mid-teens on higher volume Expect lower margins fo r eth ylene and ethylene -based products Full Year: Sales - Strong volumes are more than offset by the combined negative impact of portfolio, price and currency, resulting in sales down mid-single digits Operating Earnings - Up mid-single dig its as higher vo lumes more than offset the negative impact of currency * Segment sales in clude transfers. **See appendix for reconciliation of n on-gaap measures. ***Prior periods reflect reclassification of Viton fluoroelastomers from Performance Materials to Performance Chemicals. 4Q Operating Earnings** 4Q Sales*

35 Industr ial Biosciences Q12 4Q13 4Q14 $ in B ill io n s 4Q12 4Q13 4Q14 0.0% 5.0% 10.0% 15.0% 20.0% M a r g in $ in M ill io n s 4Q Comments Sales - Down 1 percent as 2 percent higher volumes were more than offset by the impact of currency Growth in enzymes driven by new product offerings an d increased sales into emerging markets Biomaterial sales were lower on weaker demand in k ey US mark ets Operating earning s - Up 23 percent on higher volumes, stronger product mix, and lower costs 1Q and FY Outlook 1Q: Sales & Operating Earnings Mid -single digit volume growth will be offset by the n egative impacts of currency and lower prices, resulting in sales and operating earnings even with the prior year Enzyme demand continues to be steady in ethanol, animal nutrition, and food enzyme markets Full Year: Sales - Mid-single digit volume gr owth will be offset by the impacts of currency, lower price resulting in flat sales Full Year Operating Earnings - Up in the high teens; both on higher volumes and stronger mix * Segment sales include transfers. **See app endix for reconciliation of non-gaap measures. 4 Q Operating Earnin gs** 4Q Sales*

36 * Segment sales include transfers. **See appendix for recon ciliation of non-gaap measures. Electronics & C ommunications Q12 4Q13 4Q14 $ in Billio n s 4Q12 4Q13 4Q14 0% 5% 10% 15% 20% M a rg in $ in M ill io n s 4Q Comments Sales - Down 11 percent on lower vo lumes and lower metals p rices Volume growth in several product lin es was more than offset by competitive pressures impacting Solamet paste Operating Earnings - Up 4 percent as lower costs and productivity improvements o ffset lower sales volumes 1 Q and FY Outlook 1Q: Sales - Down about 10 percent from short-term challenges in PV paste and lower metals prices; Operating Earnings - About flat benefiting from productivity Global photovoltaic (PV) module in stallations expected to grow about 20 percent Continued volume gr owth in Tedlar film, consumer electronics and packaging graphics; short-term challeng es in PV paste Full year: Sales - Up low-single digits percent on higher v olume offset by lower metals prices an d currency; Operating earnings - Up high-teens percent on higher volumes and p roductivity Expect to benefit from our new photovoltaic paste products in the second half of the y ear 4 Q Operating Earnin gs** 4Q Sales*

37 Nutrition & Health 15 * Segment sales include tran sfers. **See appendix for reconciliation of non -GAAP measures Q12 4Q1 3 4Q14 $ in Billio n s 4Q12 4Q13 4Q14 0% 3% 6% 9% 12% M a rg in $ in M ill io n s 4 Q Co mments Sales - Volume growth in cultures and probiotics was more than offset by the negative impact of currency Operating Earnings - Increased 1% as the negative impact of cu rrency and unfavorable mix wer e offset by a gain on termination of a distribution agreement of $18 million and lower costs Sixth consecutive quarter of year-over-year operatin g marg in improvement 1Q and FY Outlook 1Q: Sales & Operating Earnings Mid -single digit volume gains offset by a significant currency impact resulting in flat sales and operating earnings Market cond itions expected to remain challenging in Europe Full-year : Sales - Flat with broad-based volume gains offset b y currency Operating earnings - Up mid -single digits percent higher from higher volume, improved mix, lower raw material costs and a continued focus on productiv ity d espite significant currency headwinds Expect co ntinued full-year operating margin expansion 4Q Op erating Earnings** 4Q Sales*

38 Safety & Protection Protection Techn ologies (DPT), Building Innovations (BI), Sustainable Solutio ns (DSS) Q12 4Q13 4Q14 $ in Billio n s 4Q12 4Q13 4Q14 0% 5% 10% 15% 20% 25% M a rg in $ in M ill io n s 4Q C omments Sales - 3 percent volu me gro wth was more than offset by curren cy and portfolio impact Increased deman d in industrial markets fo r No mex ther mal resistant fib er, Kevlar high strength materials, and Tyvek protective material Operating Earnings - Flat as higher volumes an d lower costs were o ffset by portfolio changes and currency Full-year operating earnings were up 1 5 percent with operating margin s up 260 basis points 1Q and FY Outlook 1Q: Sales Volume growth of mid to high single digits percent is more th an offset by curr ency and portfolio, resulting in sales down low-single dig its on a percent basis Oper ating Earnings - Increase in the mid -single digits due to mix enrichment and continued productivity Full-year: Sales Mid single digit volu me gro wth is offset by the impact of portfolio changes resulting in sales even with the prior year Operating Earnings - Up low teens on a percentage basis as volume growth, continued margin improv ement and productiv ity partially offset b y currency and the impact of portfolio changes * Segment sales include transfers. **See appendix for reconciliation of non- GAAP measures. 4Q Operating Earnings** 4Q Sales*

39 Performance Chemicals* ** Titanium Technologies (DTT), Chemical & Fluoroprodu cts (DC&F) Q12 4Q13 4Q14 $ in Billio n s 4Q1 2 4Q13 4Q14 0% 5% 10 % 15% 20% 25 % M a rg in $ in M ill io n s 4Q Comments Sales - Down 6 percent due primarily to a 5 percent negative portfolio impact Segment volumes were up 3 percent on solid deman d for chemicals and fluor oproducts, Ti02 volumes were flat and prices were down 7% from th e prior year, 6% on a sequential basis Operating Earnings - Down 1 percent as gains fro m the sales of non-strategic assets, higher volumes and lower costs were mo re th an offset by lower segmen t prices, currency and p ortfolio impacts Current period includes a $2 3 millio n gain from the sale of a business 1Q and FY Outlo ok 1Q: Sales - Down mid-single digits; Operating earnings - Down ab out 35 p ercent; Both due primarily to lower USD pricing and the negative impact of currency Current Ti02 industry environment relatively stable with inventory levels near normal Full-year: Sales Up low single digits; volumes ex pected to grow at 1-2x GDP Operating Earnings - Flat as higher volumes are offset by the negative impact of currency and portfolio ch anges * Segment sales include transfers. **See appendix for reconciliation of non -GAAP measures. ***Pr ior periods reflect reclassification of Viton fluoroelastomers from Performance Mater ials to Performance Chemicals 4Q Operatin g Earnings** 4Q Sales*

40 APPENDIX 1: FOURTH QUARTER 2014 SEGMENT COMMENTARY This data should be read in conjunction with th e Comp any s fourth quarter earnings n ews r elease dated January 27, 2015, DuPont s 4Q 2014 Earnings Conference Call presentation materials and reconciliations o f non -GAAP to GAAP measures included in the presentation materials and posted on the DuPont Investor Center website at 1/27/

41 Segment Commentary Fourth Qu arter Earnings Agriculture In our Agriculture segment, fourth quarter sales are largely driven by th e summer and Safrinha seasons in Latin America and shipments to customers in advance of the 2015 planting seaso n in the northern hemisphere. Sales for the quarter were 4 percent below the prior year as volume gr owth in crop protection and the timing of seed shipments for the 2015 planting season were more than offset by lower corn seed sales in Brazil and the negative impact of currency. Fourth quarter operating earnings of $129 million increased $41 millio n as lower costs, productiv ity improvements and gains from portfolio actions of $36 million more than offset the d ecline in sales. For the full year, operating earnings decreased 5 percent as higher crop protection volumes, higher local seed prices an d lower costs, including seed inputs, wer e more than offset by lower corn seed volumes, the negative impact of currency and portfolio impacts. During the year we took disciplined actions to streamline our cost structure, further focus our investments on the highest growth opportunities and better position ourselves for the current econ omic environment. Crop protection sales for the quarter wer e 1 percen t lower as volu me gro wth from most regions was more than offset by the negative impact of currency and from portfolio changes. For the full year, crop protection sales grew 4 percent in a challenging market enviro nment led by insecticides and fungicides while herbicide sales declined. We saw further growth in 2014 from Rynaxypyr and from successful launches of Cyazypyr and o ur new seed treatments in several markets. Mo ving to the seed business, fourth quarter sales d eclined 7 percent due in part to str ong currency headwinds. In Brazil, corn seed market share and price were lower reflecting the impact of fall armyworm resistance. Brazil corn volumes were also negatively impacted as farmers p lanted fewer hectares of corn. Fo urth quarter shipments in North America and Europe were higher than the prior year in advance of 2015 planting. For the full year, seed sales declined 7 percent as higher local seed price from new products was more than offset by reduction s in corn plan ted area and market share declines in Brazil and North America.

42 Segment Commentary Fourth Quarter Earnings Agr iculture (continued) As we look to the near future, we ex pect the economic environment in the agriculture sector to remain challenged. Farmer net income has declined and growers in Brazil s Safrinha season and in North America are likely to reduce corn plantings again in 2015 putting pressure on volumes in the first h alf of the year. Our seed order book reflects this shift in acres. In addition, lower insect pressure in Brazil and continued elevated distributo r inventories in the Americas will present headwinds in in crop protection markets. Farmers are increasing demand for our newest corn seed genetics, our AcreMax integrated refuge corn products and our new T series soybean varieties. However, with pro fits co ming d own, farmers are sharpening their pencils when it comes to input p urchases. C oupled with strong indu stry seed supplies, continues to be a ver y dynamic and competitive season. We anticipate currencies will remain volatile and headwinds to be substan tial in markets like Europe, Brazil and Canada where we have seen strong growth in our market position in recent years. For the first half of 2015, wh ich r eflects the majority of the northern hemisphere season, we expect Agriculture segment sales to be mid-single digits percent lower with operating earnings about 10 percen t below 2014 as price gains fro m new prod uct mix are more than offset by currency and lower volu mes. The currency impact will be greatest in the first quarter when the majority of 2015 season sales in Europe occur. Volumes will be more challenged in the first quarter due to an expected decline in North America and Brazil Safrinha corn area, the earlier timing of northern hemisphere seed shipments which benefited th e fourth quarter of 20 14, and a reduction in herbicide volumes. We expect first quarter sales to be about 10 percent lower and operating earnings about 25 percen t below For the full year we expect sales to be down low-single digits percent an d operating earnings down high-single digits percent as price gains from new seed and crop protection products are more than offset by currency headwinds. Excluding the impact of currency, we wou ld ex pect operating earnings to be up mid - to high-single digits.

43 Segment Commentary Fourth Quarter Earnings Agriculture (continued) While agriculture markets may continue to face challenges in th e short-term, we remain confid ent in the long -term fundamentals for sustainab le demand growth for g rain and oilseeds and in our growth strategy. We are excited about our near -term pipeline of new genetics an d traits like event DP4114 and Leptra insect protectio n in seeds. Leptra will bring an additional mode of control to help Brazilian farmers manage the intense pressure they face from insects, including fall armyworm. In crop protection our ro bust pipeline of new actives will continue to complement our recent laun ches of insecticides and fungicides and our expanding seed treatment portfolio.

44 Segment Commentary Fourth Quarter Earn ings Performance Mater ials Positive volume and local pricing were more than offset by currency and portfolio impact, resultin g in a sales decline of 4 percent. Segment volumes increased 4 percent on solid demand in auto, packaging, industrial, and consumer markets. Demand for Performance Polymers, especially in China and North America, remained strong in the auto sector. China volumes were up approximately 15 percent year over year which more than offset lower demand in Europe, Japan, an d Ko rea. In packaging, indu strial, and consumer mar kets, specialty and co mmodity ethylene copolymer d emand remained solid and ethylene sales wer e up versu s the prior year. In the quarter, operating earnings increased 13 percent as higher volumes, prices and lower costs more than offset the negative impacts of currency and portfolio changes. Operating margins increased 340 basis po ints on favorable ethylene market dynamics and higher volumes. In 2014, full year operating earnings were up 1 percent, overcoming the n egative impacts of portfolio changes and the 60 day planned ethylene outage. Operating margins increased 70 basis p oints to close the year at 21 percent. For the first quarter, we anticipate sales will be down in the mid-single digits percent range due primarily to currency and por tfolio impacts, ex portfolio sales up mid -sin gle d igits. Operating earnings are expected to be up in the mid-teens however on a percentage basis on improved volumes as prior year sales were constrained in advance of the schedu led ethylene outage. In 2 015, we anticipate strong volumes will be more than o ffset by the combined negative impact of po rtfolio, price, and currency, resulting in sales down mid -sin gle digits. Full year operating earnings are expected to increase in the mid- single digit rang e however as higher volumes more than offset the negative impact of currency.

45 Segment Commentary Fourth Quarter Earn ings Industrial Biosciences Industrial Biosciences sales of $322 million were 1 per cent lower as 2 percent higher volumes were more than offset by the impact of curren cy. Growth in enzymes was driven by new product offerings and increased sales into emerging markets while b iomaterials volumes were lower on weaker demand in key US markets. Sales from recently launched enzyme offer ings in ethanol, animal nutrition and food enzyme markets contributed to positive volume growth in the quarter. Ethanol industry fundamentals are adjusting to a lower energy cost environment b ut demand fo r Du Pont s novel enzymes and other functional bio products designed to increase p roduction rates, yield and efficiency remained steady. In 2015, enzyme demand for ethanol production is exp ected to remain stable although ethanol pr oducer margins are expected to transition fr om their peak levels in Fourth quarter operating earnings were up 23 percent on higher v olumes with a stronger product mix and lower costs. For the full year 2014, higher volumes and improv ed mix from the continued ramp of new products helped deliver a 2 5 percent increase in operating earnings and a 30 0 basis point increase in o perating margins. For the 1 st quarter 2015, we anticipate higher segment volumes will be offset by th e negative impacts of cu rrency and lower prices, resulting in sales even with the prior year. Fir st quarter operating earnings are also ex pected to be even with th e prior year. For the full y ear, we expect sales will be flat but higher volumes and stronger mix will result in earnings up in the h igh - teens on a percentage basis.

46 Segment Commentary Fourth Quarter Earn ings Electronics & Communications Sales in Electronics & Communications were 1 1 percent lower in the fourth q uarter. Volume growth in several product lines was more than offset by competitive pressures impacting Solamet paste and the pass-through of lower metals prices. Operating earnings of $97 million increased $4 million, or 4 percent, as lower v olumes were offset by lower costs an d productivity improvements. Fu ll year sales were 6 percent lower as volume growth in several p roduct lines was more than offset by lower metals prices and by competitive pressures in photov oltaic paste. Full year operating earnings of $355 million increased $21 million, or 6 percent, on v olume growth and productivity gains, partially offset b y the absence of $20 million in OLED licensing income realized during Looking ahead to 20 15, global pho tovoltaic module installations are expected to grow about 20 percent fueled by installations in China, Jap an, the U.S. and in developing markets. We expect contin ued strength in Tedlar film, consumer electronics and packagin g graphics. In the short-term, we expect segment results will continue to be negatively impacted by declines in Solamet paste, as intense competition has impacted price and share in this business. We are the market and techn ology leader in photovo ltaics and are driving a ro bust innovation pip eline aimed at furthering solar cell efficiency and module lifetime. We have begun testing a n ew metallized paste product for the PV market with customers, and expect to ramp up production in For the first quarter we expect sales to be down about 10 percent from short-term challenges in PV paste an d lower metals prices with operating earnings ab out flat, benefitting from productivity. We exp ect to see the impact of our new p hotovoltaic paste pro ducts in the second half o f the year. Full year sales are expected to be up low-single digits percent from volume gains offset by the pass-through of lower metals prices. For the year we expect operating earnings to be up in the high-teens percent range.

47 Segment Commentary Fourth Quarter Earnings Nutrition & Health In Nutrition & Health, sales were 3 percent lower as continued volume growth in cultures and probiotics was more than offset by the negative impact of currency. Operating earnings increased $1 million as the negative impact of currency and unfavorable mix were offset by a gain on termination of a distribution agreement of $18 million and lower costs. This was the sixth consecutive quarter of year-over-year operating margin improvement. Our disciplined fo cus on productivity and mix enrichment is paying off as operating margin s improved over 200 basis points for the full year was a strong year for the segment as full year operatin g earnings grew 27 percent from improved product mix, volume growth, productivity and a gain on termination o f a distribution agreement, partially offset by the negative impact of currency. Market conditions are exp ected to remain challenging in Europ e where the Russia food import ban continues to have an effect and currency will be a strong headwind. In the first quarter, we expect sales and operating earnings to be about flat with broad-based volume gains negated by the impact of currency. Full year sales are expected to be about flat with br oad -based volume gains offset by currency. Full year operating earnings are expected to be mid-single digits percent higher benefitting from lower raw material costs, improved mix and a continued focus on productivity, further expanding operating margins.

48 Segment Commentary Fourth Quarter Earnings Safety & Protection Sales of $943 million were down 3 p ercent as v olume growth was more than offset by th e impact of the Sontara divestiture. Higher volumes in industrial markets, including demand for Nomex thermal resistant fiber, Kevlar high strength materials and Tyvek protective material, were offset by currency. Nomex demand growth was fueled by thermal industrial and energy solution s applications. Kevlar d emand growth was driven by increased sales into the pub lic and transportation sectors. Tyvek demand was driven by indu strial demand and the global Ebola response. Region ally, sales volume growth in Eu rope, the United States, and Canada, was offset by lower volumes in Latin America. Fourth quarter segment operating earn ings of $209 million were flat year over year. Operatin g earnings benefitted from improved margins, increased demand from industrial markets, lo wer costs, and continued benefits from productivity wer e offset by portfolio changes and currency. Full year 2014 operating earnings of $7 94 million increased $104 million, or 1 5 percent, from higher volumes dr iven by increased demand for Nomex thermal resistant fiber and Kevlar high strength materials, produ ctivity improvements an d lower p roduct costs, partially offset by lower sales from clean technologies offerings and portfo lio changes. Op erating margins were up 260 basis points versus prio r year. In the first qu arter 2015, vo lume growth in the mid -to -high single digits per cent will be more than offset by the impact of cur rency and portfolio changes. Operating earnings growth in the mid-single digit percent range on mix enrichment and sustained oper ational productivity. For the full year 2015, segment sales are expected to be flat and earnings up in the low- teens on a percentage basis as strong volume growth, continued margin impro vement and prod uctivity, will be offset by portfolio chan ges and currency.

49 Segment Commentary Fourth Quarter Ear nings Performance Chemicals Sales were down 6 percent due primarily to a 5 percen t neg ative portfolio impact. Volumes were up 3 percent on so lid d emand for ch emicals and flu oroproducts. In Ti02, volumes were flat an d prices were d own 7 percent from th e prio r year, 6 percent on a sequential basis. Competitive pressures in Ti02 remain high as soft industry fundamentals, especially in Europe, contributed to lower prices in the quarter. We believe industry utilization rates remain essentially unchanged with invento ry levels near normal. Operating earnings were down 1 percent as gains from the sales of no n-strategic assets, higher volumes and lower costs were more than offset by lower segment prices, currency and portfolio imp acts. The fourth quarter included a gain of $23 million from the sale of a business. For the full year 20 14, sales declined 6 percent and o perating earnings declined 8 percent due primarily to lower segment prices paired with the negative impact of portfolio changes. In the first quarter 2015, we anticipate sales will be down in the mid-single digits on a percent basis and operating earnings will be down about 35 percent due primarily to lower USD pricing. Full year 2015, segment volumes are expected to grow at 1-2 times the rate of GDP with full year sales up low-single digits on a percent basis. Full year operating earnings ar e exp ected to be about flat as higher volu mes are offset by the negative impact of currency and portfolio changes.

50 INDEX PAGE SELECTED OPERATING RESULTS 2 8 SELECTED INCOME STATEMENT DATA 2 9 SEGMENT SALES 30 SEGMENT PRETAX OPERATING INCOME 31 SEGMENT OPERATING EARNINGS 32 SIGNIFICANT ITEMS BY SEGMENT - PRETAX OPERATING INCOME 33 RECONCILIATION OF NON-GAAP MEASURES RECONCILIATION OF BASE INCOME TAX RATE TO EFFECTIVE INCOME TAX RATE 37 Note: Management believes that an an alysis of op erating earnings (as defined on page 28), a "non-gaap" measure, is mean ingful to in vestors because it provides insight with respect to ongoing operating results of the company. Such measurements are not recognized in accordan ce with generally accepted accounting principles ( GAAP) and should not be viewed as an alternative to GAAP measures of performan ce. E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES QUARTERLY SUPPLEMENTAL FINANCIAL DATA AND NON- GAAP RECONCILIATIONS (UNAUDITED) DECEMBER 31, 20 14

51 4Q14 Supplemental Financial Data and Non-GAAP Reconciliations 28 1/27/2015 E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES Year Year Year Year Q14 3Q14 2Q14 1Q Q1 3 3Q13 2Q13 1Q Q12 3Q12 2Q1 2 1Q INCOME STATEMENT DATA Con solidated Net Sales 34,723 7,3 78 7,511 9,706 10,128 35,734 7,747 7,735 9,844 10,408 34,812 7,325 7,390 9,917 10, ,681 Operating Earnings After Income Taxes, 3, ,0 85 1,472 3, ,189 1,459 3, ,421 1,547 3,790 Attributable to DuPont (1) Significan t Items - After-tax (9) 39 (44) 8 (12) (423) (294) (71) (78) 20 (680) (91 ) (342) (215) (32) (237) Non -Operating Pensio n & OPEB Costs - After-tax (84) (20) (20) (23) (21 ) (360) (81) (95) (85) (99) (439) (99) (106) (116) (1 18) (361) Income from Continuing Operations After Income Taxes Attribu table to DuPont 3, ,070 1,439 2, ,02 6 1,380 2,447 3 (43) 1,090 1,397 3,192 Depreciation 1, , , ,199 STATEMENT OF CASH FLOW DATA (2) Cash Provided by (Used for) Operating Activities 3,712 5, (2,421) 3,179 5, (2,667) 4,849 5, (1,877) 5,152 Capital Ex penditures (3) 2, , , ,910 (1) Operating earnings are defined as earnings from continuing operations (GAAP) ex cluding significant items and non-operating pension and other post-employment benefit (OPEB) costs. ( 2) Data is on a total company basis. (3 ) Includes purchases of property, plant and equipment and investment in affiliates. Note: The data above provides a historical display of Selected Income Statemen t Data included in o ur Quarterly Earnings Release financials. See Quarterly Earnin gs Release fin ancials for fu ll details, includ ing details on "Sign ificant Items". SELECTED OPERATING RESULTS (UNAUDITED) ( dollars in millions)

52 4Q14 Supplemental Financial Data and Non-GAAP Reconciliations 2 9 1/27/2015 E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES Year Year Year Year Q1 4 3Q14 2Q14 1Q Q13 3Q13 2Q1 3 1Q Q12 3Q12 2Q12 1Q Consolidated Net Sales 34,723 7,378 7,511 9,706 10,128 35,734 7,747 7,735 9,844 10,408 34,812 7,32 5 7,390 9,917 10,180 33,6 81 Segment Sales 35,011 7,439 7,580 9,783 10, ,046 7,814 7,813 9, ,494 35,194 7,397 7,480 10,022 10, ,087 Seg ment Operating Earnings (1) 5,955 1, ,7 70 2,248 5, ,857 2,276 6, ,241 2,473 6,292 Adjusted EBIT (Operatin g Earnings) (1) (2) 5, ,529 1,945 5, ,693 2,066 5, ,058 2,129 5,293 Adjusted EBITDA (Operating Ear nings) (1) (2) 7,052 1,371 1,327 1,972 2,382 6,624 1, ,09 7 2,499 6, ,007 2,475 2,556 6,744 Operating Earn ings Before Income Taxes (1) 5, ,439 1,848 4, ,582 1,956 4, ,950 2,027 4,886 Operating Earnings Per Share (1) (3) (1) See Reconciliation of Non -GAAP Measur es. (2) Adjusted EBI T from operating earnings is operating earnings (as defined on page 28) b efore income taxes, net income attrib utable to noncontrolling interests and interest expense. Adjusted EBITDA from operating earnings is adjusted EBIT from op erating earnings before depreciation and amortization of intangible assets. (3) Earnings per share for the year may not equal the sum of quarterly earnin gs per share due to changes in aver age share calculation s. Note: SELEC TED INCOME STATEMENT DATA OPERATING EARNINGS ( UNAUDITED) (dollars in millions, except p er share) The data above provides a historical display of Selected I ncome Statement Data included in o ur Quarterly Earnings Release financials. See Quarterly Earning s Release fin ancials for fu ll details, includ ing details on "Significant Items".

53 4Q14 Supplemental Financial Data and Non -GAAP Reconciliations 30 1 /27/2015 E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES Year Year Year Year Q14 3 Q14 2Q14 1Q Q13 3Q13 2Q13 1 Q Q12 3Q12 2Q12 1Q Agricultur e 11,304 1,732 1,563 3,615 4,394 11,739 1,806 1,633 3,631 4,669 10,426 1,535 1,423 3,388 4,080 9,166 Electronics & Communications 2, , , ,173 Industrial Biosciences 1, , , Nutrition & Health 3, , , ,4 60 Performance Chemicals(1) 6,49 7 1,564 1,646 1,696 1,591 6,932 1,671 1,781 1,837 1,643 7,450 1,644 1,794 2,043 1,969 8,055 Performance Materials(1) 6,129 1,461 1,552 1,582 1,534 6,2 39 1,521 1,602 1,615 1,50 1 6,185 1,478 1,552 1,624 1,531 6,554 Safety & Protection 3, , , , , ,934 Other Total Segment Sales 35,011 7,439 7,58 0 9,783 10,209 36,046 7,8 14 7,813 9,925 10,494 35,194 7,397 7,480 10,022 10,295 34,087 Elimination of Transfers (288) (61 ) (69) (77) (8 1) (312) (67) (78) (81) (86) (382) (72) (90) (105) (1 15) (406) CONSOLIDATED NET SALES 34,723 7,378 7,511 9,706 10,128 35,734 7,747 7,735 9,844 10,408 34,812 7,325 7,390 9,917 10,180 33,681 (1) Prior periods reflect the reclassifications of Vito n fluoro elastomers from Performance Materials to Perfo rmance Chemicals. Note: The d ata above provides a historical display of selected data included in our Quarterly Earnings Release financials. SEGMENT SALES SEGMENT SALES (UNAUDITED) (dollars in millions)

54 4Q14 Supplemental Financial Data and Non-GAAP Reconciliations 31 1/2 7/2015 E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES Year Year Year Year Q14 3Q14 2Q14 1Q Q13 3Q13 2Q13 1Q Q12 3Q12 2Q12 1Q Agriculture 2, (55) 789 1,442 2,132 (108) (1 02) 861 1,48 1 1,669 (103 ) (198) 682 1,288 1,566 Electron ics & Commun ications (38) (99) Industrial Biosciences Nutrition & Health Performance Chemicals(1) , ,162 Performance Materials(1 ) 1, , , ,031 Safety & Protection Oth er (391) (132) (83) (84) (92) (340) (91) (107) (5 5) (87) (412) (80) (75) (208) (49) (55) TOTAL SEGMENT PRETAX OPERATING INCOME 6,356 1, ,955 2,248 5, ,777 2,241 5, ,961 2,423 5,8 81 Net Exchange Gains (Losses) (109) ( 96) (128) (73) (101) (215) (54) (130) 50 (81) (146) Non -Operatin g Pension & OPEBs Costs (124) (30) (30) (34) (30) (539) (124) (1 42) (126) (147) (654) (147 ) (157) (174) (176) (540) Corporate Expenses (999 ) (272) (232) (278) (217) (765) (183) (1 62) (206) (214) (948) (240 ) (233) (224) (251) (869) Inter est Ex pense (377) (87) (93) (94) (103) (44 8) (108) (108) (115) (117 ) (464) (117) (116) (117) (114) (447) INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 4, ,4 40 1,802 3, ,365 1,774 3,088 (34) (175 ) 1,496 1,801 3,879 (1,37 0) (295) (352) (366) (357) (626) (335) (387) (6 16) ( 397) (392) (647) INCOME (LOSS) FROM CONTINUING OPERATIONS AFTER INCOME TAXES 3, ,074 1,445 2, ,030 1,387 2,472 4 (40) 1,099 1,409 3,232 ( 1) Pr ior periods reflect the reclassifications of Viton fluoroelastomers from Performance Materials to Performance Chemicals. Note: The data ab ove provides a historical display of selected data included in our Quarterly Earnin gs Release financials. SEGMENT PRETAX OPERATING INCOME (LOSS) INCOME FR OM CONTINUING OPERATIONS (UNAUDITED) (dollars in millions) (Provision For) Benefit Fr om Income Taxes o n Continuing Operations

55 4Q14 Supplemen tal Financial Data and Non-GAAP Reconciliatio ns 3 2 1/27/2015 E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES Year Year Year Year Q14 3Q1 4 2Q14 1Q Q13 3Q13 2Q1 3 1Q Q12 3Q12 2Q12 1Q Agriculture 2, (55) 836 1,442 2, (62) 941 1,516 2,138 (77) (70) 947 1,338 1,791 Electronics & Communications Industrial Biosciences Nutrition & Health Performance Chemicals(1) , , ,162 Performance Materials(1) 1, , , Safety & Protection Other (369) (112) (83) (82) (92) (34 5) (96) (107) (55) (87) (286) (91) (75) (71) (49) (27 ) TOTAL SEGMENT OPERATING EARNINGS 5,95 5 1, ,770 2,248 5, ,857 2,276 6, ,241 2,473 6,292 Corporate Expenses (702) (144) (171) (186 ) (201) (762) (191) (162) (195) (214) (8 64) (215) (174) (224) (251 ) (813) Interest Expense (377) (8 7) (93) (94) ( 103) (448) (108) (108) (11 5) (117) (464) (117) (116 ) (117) (114) (447) 4, ,490 1,944 4, ,54 7 1,945 4, ,9 00 2,108 5,032 (938) (71) (122) (347) (398) (983) (43) (111) (37 3) (456) (1,19 0) (61) (164) (460) (505) (1,137) Net After -tax Exhange (Losses) Gains (224) (63) (39 ) (54) (68) (8 6) (39) (43) 19 (23) (142) (29) (59) (10) (44) (65) Less: Net Income Attr. to Noncontrollin g Interests OPERATING EARNINGS 3, ,085 1,472 3, ,189 1,459 3, ,421 1,547 3,790 Net Income Attributable to Noncontrolling Interests Non-Operating Pension & OPEB Costs - After-tax (84) (20) (2 0) (23) (21) ( 360) (81) (95) (85) (99) (439) (99) (106 ) (116) (118) (361) Significant Items - After-tax (9) 39 (44) 8 (12) (423) (294) (71) (78) 20 (680) (91) (342) (2 15) (32) (237) INCOME (LOSS) FROM CONTINUING OPERATI ONS AFTER INCOME TAXES 3, ,074 1,445 2, ,030 1,387 2,472 4 (40 ) 1,099 1,409 3,232 (1) Prio r periods reflect the r eclassifications of Viton fluoroelastomers from Performance Materials to Performance Chemicals. Note: The data above provides a historical display of selected data inclu ded in our Quarterly Earnings Release financials. OPERATING EARNINGS BEFORE INCOME TAXES AND EXCHANGE (LOSSES) GAINS Provision For Income Taxes on Operating Earnings, Excluding Taxes on Exchange (Losses) Gains SEGMENT OPERATI NG EARNINGS OPER ATING EARNI NGS (UNAUDITED) (dollars in millions)

56 4Q14 Supplemental Financial Data and Non-GAAP Reconciliation s 33 1/27/2015 E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES SEGMENT PRETAX IMPACT OF Year Year Year Year SIGNI FICANT ITEMS Q14 3 Q14 2Q14 1Q Q13 3Q13 2 Q13 1Q Q12 3Q12 2Q12 1Q Agricultu re (47) - (351) (196) (40) (80) (35) (46 9) (26) (128) (265) (50) (225) Electronics & Communications (84) (16 ) - (68) - (131) (131) (37) (2) (157) Industrial Biosciences (13) (11) - (2) (3) - (3) - - (79) Nutrition & Health (15) (7) - (8) (49 ) (36) (13) - - (126) Performance Chemicals (21) (2) - (19) - (74) (2) (72) - - (36) (33) (3 ) Performance Materials 292 (70) (16) ( 16) (104) (3) (101) Safety & Protection (5 2) (21) - (31) (58 ) (3) (55) Other (2 2) (20) - (2) (126 ) 11 - (137) - (28) TOTAL SIGNIFICANT ITEMS BY SEGMENT - PRETAX (556) (329) ( 112) (80) (35) (882) (92) (460) (280) (5 0) (411) Note: The data above provid es a historical d isplay of significant items included in our Quarterly Earn ings Release financials. SIGNIFICANT ITEMS BY SEGMENT - PRETAX OPERATING INCOME (UNAUDITED) (dollars in millions)

57 4Q14 Supplemental Financial Data and Non-GAAP Reconciliations 34 1/27/2015 E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES Year Year Year Year Q14 3Q14 2Q14 1Q Q13 3Q13 2Q13 1Q Q12 3Q12 2Q12 1Q RECONCILIATI ON OF DILUTED EPS (1) Operating EPS Non-Operating Pension & OPEB Costs (0.10 ) (0.02) (0.02) (0.03) (0.0 3) (0.39) (0.09) (0.09) (0.1 0) (0.11) (0.46) (0.11) (0.1 1) (0.12) (0.12) (0.39) Significant Items (0.01) 0.04 (0.05) 0.01 (0.0 1) (0.45) (0.31) (0.08) (0.08) 0.02 (0.72) (0.09) (0.3 7) (0.23) (0.04) (0.25) GAAP EPS from continuing oper ations (0.05) RECONCILIATION OF SEGMENT PTOI Segment Operating Earnings 5,955 1, ,770 2,248 5, ,857 2,276 6, ,241 2,473 6,292 Significant Items included in Segment PTOI (556) (3 29) (112) (80) (35) (882) (92) (460) (28 0) (50) (411) Segment PTOI 6,356 1, ,955 2,248 5, ,777 2,241 5, ,961 2,423 5,881 RECONCILIATION OF ADJUSTED EBIT / ADJUSTED EBITDA TO CONSOLIDATED INCOME STATEMENTS Income From Continuing Operations Befor e Income Taxes 4, ,440 1,802 3, ,365 1,774 3,088 (34) ( 175) 1,496 1,801 3,879 Add: Significant Items - Pretax - (Benefit) / Charge (46) (88) 61 (35) Ad d: Non-Operating Pension & OPEB Costs - Pretax Operating Earnings Before Income Taxes 5, ,439 1,84 8 4, ,582 1,9 56 4, ,950 2,027 4,886 Less: Net Income Attr ibutable to Noncontrolling Interests Add: Inter est Expense Adjusted EBIT (Operating Earnings) 5, ,529 1,945 5, ,693 2,06 6 5, ,058 2,1 29 5,293 Add: Depreciation and Amortization 1, , , ,4 51 Adjusted EBITDA (Operating Earnin gs) 7,052 1,371 1,327 1,972 2,382 6,624 1, ,097 2,499 6, ,007 2,475 2,556 6,7 44 (1) Earnings per share for the year may not equal the sum of quarterly earnings per share du e to chan ges in average share calculations. RECONCILIATION OF NON-GAAP MEASURES ( UNAUDITED) (dollars in millions, except p er share)

58 4Q14 Supplemental Financial Data and Non-GAAP Reco nciliation s 35 1/27/2015 E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES Dec-14 Sep -14 Jun-14 Mar -14 Dec-13 Sep -13 Ju n-13 Mar -13 Dec-12 Sep-12 Jun-12 Mar -1 2 Dec-11 CALCULATION OF NET DEBT Cash and Cash Equivalents 6,910 3,982 4,174 3,782 8,941 7,005 6,685 6,555 4,284 3,418 3,506 3,410 3,586 Marketab le Securities Total Cash 7,034 4,548 4,3 47 3,849 9,086 7,189 6,89 6 6,581 4,407 3,523 3,556 3,601 4,019 Short-Term Borr owings and Capital Lease Oblig ations 1,423 3,889 2,506 2,019 1,721 4,204 3,315 2,006 1,275 4,564 3,696 3, Long-Term Borrowings and Capital Lease Obligations 9,271 9,279 9,292 9,298 10,741 10,755 10,765 11,279 10,465 10, ,254 11,232 11,736 Total Debt 10,694 13,168 11,798 11, ,462 14,959 14,080 13,285 11,740 15,066 14, ,825 12,553 Net Debt (Non-GAAP) 3,660 8,620 7,451 7,468 3,376 7,770 7,184 6,704 7, ,543 11,394 11,224 8,534 Year Year Year Year Q14 3Q14 2Q14 1Q Q13 3Q13 2Q13 1Q Q12 3Q12 2Q12 1Q CALCULATION OF FREE CASH FLOW Cash Provided by (Used for) Operatin g Activities 3,712 5, (2,421) 3,179 5, (2,667) 4,849 5, (1,877) 5,152 Less: Pur chases of Property, Plant and Eq uipment 2, , , ,843 Free Cash Flow 1,69 2 4,805 (261 ) (111) (2,74 1) 1,297 4,853 (168) (400) (2,988) 3,056 4, (2,178) 3,309 RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) (dollars in millions)

59 4Q14 Supplemental Financial Data and Non-GAAP Reconciliations 36 1/27/2015 E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES Year Year Year Year Q14 3Q14 2Q14 1Q Q1 3 3Q13 2Q13 1Q Q12 3Q12 2Q12 1Q SEGMENT PTOI MARGIN % (PTOI / Segment Sales) (1) Agriculture 23.6% 28.4% -3.5 % 21.8% 32.8% 18.2% -6.0% -6.2% 23.7% 31.7% 16.0% -6.7% -13.9% 20.1% 31.6% 17.1% Electronics & Communications 11.3% 14.1% 15.1% 3.4% 12.9% 8.0% -5.9% 15.2 % 14.5% 8.0% 8.2% 6.6% -16.3% 27.8% 8.7% 13.8% Industrial Bio sciences 15.7% 11.8% 14.8% 18.0% 18.6% 1 3.9% 12.6% 14.8% 14.1% 1 4.2% 13.5% 13.7% 12.7% 14.0% 13.5% 0.3 % Nu trition & Health 10.3% 8.9% 11.1% 10.5% 10.8% 8.8% 10.0% 9.3% 7.1% 8.8 % 7.9% 2.6% 7.3% 11.9% 9.8 % 3.1% Performance Chemicals(2) 14.1% 14.5% 1 5.1% 13.7% 12.9% 13.6% 13.6% 10.6% 14.6% 15.6% 24.5% 12.8% 23.2% 30.0% 29.8% 26.8% Performance Materials(2) 25.9% 17.9% 23.8% 42.0% 19.1% 20.3% 18.3% 22.9% 20.6 % 19.1% 17.3% 17.8% 14.4 % 20.0% 17.1% 15.7% Safety & Pro tection 19.0% 19.9 % 20.6% 17.3% 18.5% 17.9% 21.8% 17.4% 16.9% 15.2% 14.7% 13.5% 9.9% 18.4% 16.9% 16.8% TOTAL SEGMENT PTOI MARGIN % 18.2 % 16.5% 12.2% 20.0% 22.0% 14.9% 7.8% 9.5% 17.9% 21.4% 15.3% 7.1% 6.2% 19.6% 23.5% 17.3% SEGMENT OPERATING EARNINGS MARGIN % (Operating Earnings / Segment Sales) (1) Agriculture 20.8% 7.4% -3.5% 23.1% 32.8% 21.2% 4.9% -3.8% 25.9% 32.5% 20.5% -5.0% -4.9% 28.0% 32.8% 19.5% Electronics & Communications 14.8% 16.9% 15.1% 14.4% 12.9 % 13.1% 14.5% 15.2% 14.5 % 8.0% 9.6% 6.9% 9.6% 12.5 % 8.7% 13.8% Industrial Biosciences 16.8% 15.2% 14.8% 18.6% 18.6% 13.8% 12.3% 14.8% 14.1 % 14.2% 13.7% 13.7% 13.7% 14.0% 13.5% 11.5% Nutrition & Health 10.8% 9.7 % 11.1% 11.3% 10.8% 8.6% 9.3% 9.3% 7.1% 8.8% 9.3% 6.8% 8.8% 11.9% 9.8% 8.2% Performance Chemicals(2) 14.4% 14.6% 15.1% 14.8% 12.9% 14.6% 13.8% 14.7% 14.6% 15.6% 25.0% 14.8% 23.4% 30.0 % 29.8% 26.8% Performance Materials(2) 21.2% 22.7% 23.8% 19.2% 19.1% 20.5 % 19.3% 22.9% 20.6% 19.1 % 19.0% 18.0% 20.9% 20.0% 17.1% 15.0% Safety & Protection 20.4% 22.2% 20.6% 20.3% 18.5% 17.8% 21.4% 17.4% 16.9% 15.2% 16.2% 13.8% 15.7% 1 8.4% 16.9% 16.8% 17.0% 1 3.6% 12.2% 18.1% 22.0% 16.4% 12.0% 10.9% 18.7% 21.7% 17.8% 8.3 % 12.3% 22.4% 24.0% 18.5% (2) Prior periods reflect th e reclassification s of Viton fluoroelastomers from Perfo rmance Materials to Performance Chemicals. TOTAL SEGMENT OPERATING EARNINGS MARGIN % RECONCILIATION OF NON-GAAP MEASURES (UNAUDITED) (1) Seg ment PTOI / Oper ating Earnings margin %'s for Other (which includes the previous Pharmaceuticals segment) are not presented separately above as they are not meaningful; however, the results are included in the Total margin %'s above.

60 4Q14 Supplemental Financial Data and Non-GAAP Reconciliations 37 1/27/2015 E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES 2015 Outlook Actual Effective income tax rate 21.0% 27.4% Significant items effect and non-operating pension/opeb costs effect 1.0% (0.7%) 22.0% 26.7% Exchange gains (losses) effect2 0% (7.5%) Base income tax rate from continuing operations 2 2.0% 19.2% 1 - Represents the company' s anticipated full year tax rates. 2 - The company does not forecast the impact of exchange gains (losses) on the projected tax rate. Tax rate, from continu ing operations, before significant items and non-o perating pension/opeb costs RECONCILIATION OF BASE INCOME TAX RATE TO EFFECTIVE I NCOME TAX RATE (UNAUDITED) Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items and non-operating pension/opeb costs. Year ended December 31,

61 Copyrig ht 2014 DuPon t or its affiliates. All rights reserved. The DuPont Oval Logo, DuPont, The miracles of science and all products denoted with or are registered trademarks or trademarks of E. I. du Pont de Nemours and Company or its affiliates. Images rep roduced by E. I. du Pont de Nemou rs and Comp any under license from the National Geogr aphic Society. o p right 2015 DuPont or its affiliates. All rights reserved. on t val Logo, DuPont, The miracles of science and all products, unless otherwise indicated, denoted with or are registered trademark s or trademarks o f E. I. du Pont de Nemours and C ompany or its affiliates. Images repro duced by E. I. du Pont de Nemours and Company under license from th e National Geographic So ciety. National Geographic Image